SCHEMBL7470737

SCHEMBL7470737

C=C(Cl)Cc1nc2ccccc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.56
NPC1 O15118 6/20 0.56
DDAH1 O94760 1/20 0.56
POLB P06746 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.55
ALDH1A1 P00352 3/20 0.55
MAPT P10636 3/20 0.55
HSD17B10 Q99714 2/20 0.55
KDM4E B2RXH2 2/20 0.55
GAA P10253 2/20 0.53
BCHE P06276 1/20 0.51
CHRM1 P11229 1/20 0.51
PKM P14618 1/20 0.50
TSHR P16473 2/20 0.49
LMNA P02545 1/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CYP1A2 P05177 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7732696 0.84 DDAH1 (0.58) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL7160207 0.84 DDAH1 (0.58) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL29642026 0.83 DDAH1 (0.61) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL14361902 0.83 DDAH1 (0.61) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL8017570 0.80 ALDH1A1 (0.57) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL11498671 0.79 ALDH1A1 (0.58) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL761148 0.77 CHRM1 (0.71) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL10892813 0.77 GAA (0.59) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL7435327 0.76 DDAH1 (0.56) RAB9ANPC1DDAH1POLBSMN1; SMN2
SCHEMBL10337354 0.76 ALDH1A1 (0.68) RAB9ANPC1DDAH1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5449682-A Angiotensin II antagonists incorporating a substituted benzyl element MERCK & CO., INC. (US) 1995-09-12 US disclosed
US-5240938-A Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring MERCK & CO., INC. (US) 1993-08-31 US disclosed
EP-0543491-A2 Angiotensin II antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering MERCK & CO. INC. (US) 1993-05-26 EP disclosed
US-5187159-A Hypotensive agents, psychological disorders MERCK & CO., INC. (US) 1993-02-16 US disclosed
US-5177074-A Heterocyclic nitrogen compounds used to treat hypertension, cognitive dysfunction, anxiety or depression MERCK & CO., INC. (US) 1993-01-05 US disclosed
EP-0513979-A1 Angiotensin II antagonists incorporating a substituted thiophene or furan MERCK & CO. INC. (US) 1992-11-19 EP disclosed
EP-0510813-A1 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle MERCK & CO. INC. (US) 1992-10-28 EP disclosed
EP-0508723-A1 Angiotensin II antagonists incorporating an indole or dihydroindole MERCK & CO. INC. (US) 1992-10-14 EP disclosed
US-5151435-A Hypotensive agents, glaucoma and cognition activators MERCK & CO., INC. (US) 1992-09-29 US disclosed
US-5128327-A Hypotensive agents; congestive heart failure; antidepressants; anxiolytic agents; cognition activators MERCK & CO., INC. (US) 1992-07-07 US disclosed
WO-1991011999-A1 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO., INC. (US) 1991-08-22 WO disclosed
EP-0400835-A1 Substituted benzimidazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1990-12-05 EP disclosed